Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +17.86% | 0.00% | +9.27% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
Performance
1 day | +17.86% | ||
Current month | +17.86% | ||
1 month | +14.58% | ||
3 months | +11.11% | ||
6 months | +17.02% | ||
Current year | +9.27% | ||
1 year | -3.50% | ||
3 years | -66.05% | ||
5 years | -77.55% | ||
10 years | -90.98% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Specialty & Advanced Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+17.86% | 0.00% | +9.27% | -3.50% | 65.99M | ||
-1.56% | -1.21% | +10.23% | -5.17% | 9.11B | ||
0.00% | +1.36% | -10.76% | +26.73% | 5.21B | ||
-1.31% | -0.19% | +51.58% | +119.87% | 4.83B | ||
+4.59% | +8.25% | +12.50% | +41.59% | 4.09B | ||
+0.91% | -7.51% | -20.70% | -40.27% | 2.35B | ||
-1.11% | -6.63% | +12.83% | -9.78% | 2.32B | ||
-4.41% | -0.43% | +19.51% | -3.54% | 2.27B | ||
+1.02% | -7.51% | -29.65% | -44.77% | 2.19B | ||
-.--% | -.--% | - | - | 1.64B | ||
-0.34% | -0.16% | -0.09% | -17.83% | 1.6B | ||
+0.63% | -8.20% | +2.05% | -2.06% | 1.26B | ||
-1.17% | -3.10% | -19.18% | -27.67% | 1.06B | ||
+0.64% | -1.86% | +2.27% | +5.97% | 894M | ||
+6.15% | +15.09% | +42.30% | +46.43% | 876M | ||
+0.45% | 0.00% | -12.55% | -26.89% | 833M | ||
Average | +1.51% | -0.88% | +4.64% | +3.94% | ||
Weighted average by Cap. | +0.02% | -0.75% | +7.95% | +14.93% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +9.27% | ||
2023 | -12.72% | ||
2022 | -56.86% | ||
2021 | -25.74% | ||
2020 | -18.18% | ||
2019 | +5.60% | ||
2018 | +41.40% | ||
2017 | +6.51% | ||
2016 | -40.71% | ||
2015 | -65.52% | ||
2014 | -20.39% | ||
2013 | +2.86% |
- Stock Market
- Equities
- ORX Stock
- ORXOY Stock
- Quotes Orexo AB